Lombard Medical Technologies (LMT)

 127.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 243.00p
  • 52 Week Low: 110.00p
  • Currency: UK Pounds
  • Shares Issued: 20.16m
  • Volume: 366
  • Market Cap: £25.71m
  • RiskGrade: 180
  • Beta: 0.06

LMT Overview

The Company is a medical device company developing stent grafts and other medical products for use in the treatment of vascular disease. The Company’s lead product is named Aorfix, an endovascular stent graft for the treatment of abdominal aortic aneurysms.

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -285.3% -215.8%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.4 5.0
Pr/Book 2.1  
Latest F'cast
Revenue 33.4% 27.8%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

LMT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-07 1.01 (10.85) (3,110.00)p n/a n/a n/a n/a 0.0%
31-Dec-08 1.89 (11.44) (1,438.00)p n/a n/a n/a n/a 0.0%
31-Dec-09 2.35 (7.79) (176.00)p n/a n/a n/a n/a 0.0%
31-Dec-10 3.01 (8.69) (76.00)p n/a n/a n/a n/a 0.0%
31-Dec-11 4.01 (11.39) (62.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

LMT Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 5.13 (11.06) (46.75)p n/a n/a n/a n/a 0.0%
31-Dec-13 11.65 (10.62) (33.75)p n/a n/a n/a n/a 0.0%

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

LMT Company Announcements

Result of AGM 24-May-2012 13:05 RNS
Strategic Partnership with Machine Solutions Inc. 10-May-2012 07:00 RNS-R
Regulatory Update 02-May-2012 07:00 RNS

Latest LMT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

LMT Market Data

Currency UK Pounds
Share Price 127.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 243.00p
52 Week Low 110.00p
Volume 366
Shares Issued 20.16m
Market Cap £25.71m
Beta 0.06
RiskGrade 180

LMT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.23% below the market average27.23% below the market average27.23% below the market average27.23% below the market average27.23% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
28.82% below the market average28.82% below the market average28.82% below the market average28.82% below the market average28.82% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Income Not Available
Growth
46.58% above the market average46.58% above the market average46.58% above the market average46.58% above the market average46.58% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

LMT Dividends

No dividends found

Trades for 25-May-2012

Time Volume / Share Price
12:53 366 @ 127.75p

LMT Key Personnel

CEO Simon Hubbert
CFO Ian Ardill

Top of Page